INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 46h ago
HOUSE PTR6h ago
SEC 13F6h ago
ROBINHOOD CHAIN6h ago
SEC FORM 4/Grant or awardVerified data

Maersk-Moller Kimberly reported MDXG

Chief Commercial Officer · MIMEDX GROUP, INC. · Common Stock

Side
A
Value
—
Shares
74.2K
Price
—
Executed
Mar 4, 2026
Disclosed
Mar 6, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Mar 4 executedMar 6, 2026 disclosed

MDXG · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
13/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+9 / 25

No reported dollar value · 30.8% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+4 / 15

    1 prior trade recorded in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · MDXG

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    5
    MK
    Maersk-Moller KimberlyChief Commercial Officer
    MDXGMIMEDX GROUP, INC.
    Tax withholding
    		F$30K
    6,762 sh
    		Mar 13, 2026Mar 17, 2026
    traded Mar 13, 2026
    		+4dSEC FORM 4

    Evidence

    12
    MK
    Maersk-Moller KimberlyChief Commercial Officer
    MDXGMIMEDX GROUP, INC.
    Tax withholding
    		F$96K
    21.3K sh
    		Mar 10, 2026Mar 12, 2026
    traded Mar 10, 2026
    		+2dSEC FORM 4

    Evidence

    12
    MK
    Maersk-Moller KimberlyChief Commercial Officer
    MDXGMIMEDX GROUP, INC.
    Option exercise
    		M$193K
    42.8K sh
    		Mar 10, 2026Mar 12, 2026
    traded Mar 10, 2026
    		+2dSEC FORM 4

    Evidence

    17
    MK
    Maersk-Moller KimberlyChief Commercial Officer
    MDXGMIMEDX GROUP, INC.
    Grant or award
    		A—
    62.1K sh
    		Mar 4, 2026Mar 6, 2026
    traded Mar 4, 2026
    		+2dSEC FORM 4

    Evidence

    31
    MK
    Maersk-Moller KimberlyChief Commercial Officer
    MDXGMIMEDX GROUP, INC.
    Open-market sale
    		SELL$432K
    58.3K sh
    		Nov 6, 2025Nov 10, 2025
    traded Nov 6, 2025
    		+4dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002029167-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Mar 4, 2026
    Published
    Mar 6, 2026
    Ingested by INSIDER
    Nov 5, 04:13 UTC
    Last re-read
    Nov 5, 04:13 UTC

    Extracted facts

    Filer
    Maersk-Moller Kimberly
    Role
    Chief Commercial Officer
    Transaction
    Grant or awardAs filed: “A”
    Asset
    MIMEDX GROUP, INC.
    Ticker
    MDXG
    Shares
    74.2K
    Price per share
    $0
    Execution date (reported)
    Mar 4, 2026
    Owned after transaction
    314.6K shares
    Days from execution to publication
    2

    What this establishes

    Maersk-Moller Kimberly filed this Form 4 reporting a grant or award of MDXG on Mar 4, 2026. It became public on Mar 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Commercial Officer
    Maersk-Moller Kimberlycik:0002029167
    Issuer
    MIMEDX GROUP, INC.cik:0001376339

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.